TGM2 and cancer: Aberrant TG2 expression and/or activity are increasingly associated with the pathogenesis of a number of disorders, e.g., autoimmune diseases, fibrotic diseases, cancer, and diseases of the central nervous system (Siegel and Khosla 2007).